News Focus
News Focus
Followers 64
Posts 3399
Boards Moderated 0
Alias Born 07/26/2012

Re: PharmD08 post# 76052

Saturday, 09/24/2016 12:18:23 PM

Saturday, September 24, 2016 12:18:23 PM

Post# of 818156
If this if your first post at lease under this alias name, and you have been following the company for years as an investor. Than While release your first post with a whole lotta of negative. Why shoot holes all into your investment. adam and the crew has already tried to do this. I'am the opposite, I believe Northwest is going to get approval for DCVax-L for the treatment of Brain Cancer.

NorthWest bio has open P3 clinical trial all over the world. Not only because they want to expand their DCVax clinical trial studies all over the world, but also to have medical professional fully trained in administrating the DCVax procedures correctly for patient care. Especially when the P3 clinical trial is completed and FDA approval. NorthWest Bio will have no need to wait until the last minute to start training medical staff how to administrate the therapeutics treatment for each patient in different parts of the world, because they will have the train medical staff professional before DCVax-L is made available commercialize.

IMO P3 continuing clinical trial study is mostly all about training future medical staff how to correctly administrate DCVax-L and the type of care for each patient. The FDA approval is in the bag.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News